A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
This study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs?
This study would like to find out if this approach is better or worse than the usual approach for prostate cancer.
The usual approach for patients who are not in a study is hormone treatment with Androgen Deprivation Therapy (ADT) and Androgen-Receptor Pathway Inhibitor (ARPI).
This is an international multi-centre, open-label, randomized phase III trial comparing Docetaxel chemotherapy added to standard of care Androgen Deprivation Therapy (ADT) + Androgen-Receptor Pathway Inhibitor (ARPI) versus standard of care Androgen Deprivation Therapy (ADT) + Androgen-Receptor Pathway Inhibitor (ARPI) in participants with metastatic castration sensitive prostate cancer (mCSPC) who have a suboptimal PSA response after 6-12 months of androgen-targeting therapy.
Inclusion Criteria:
Exclusion Criteria:
Confirmed PSA progression, defined by an increase in PSA of 25% above the nadir since achieving castration on ADT, an absolute increase in PSA value of 2.0 ng/ml (ug/L) above nadir, and a subsequent increase in PSA of 25% further separated by 3 or more weeks.
Evidence of confirmed radiographic progression or clinical progression since start of ADT. Participants may be enrolled on the study if, in the opinion of the investigator, any new bone lesions on bone scan and CT represent flare or treatment effect.
Docetaxel criteria:
Clinically significant cardiac disease including:
Patients with uncontrolled intercurrent illness or any other significant condition(s) that would make this protocol unreasonably hazardous.
Patients with a prior or concurrent malignancy whose natural history of treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial.
Concurrent treatment with other anti-cancer systemic therapy other than ADT and ARPI.
Live attenuated vaccination administered within 30 days prior to enrollment/randomization.
For participants with a history of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.
Participants with a history of hepatitis C virus (HCV) infection must have been treated and cured. For participants with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load.
High-grade neuroendocrine prostate cancer or small cell features (except if a participant has no histological diagnosis but a PSA >100 ng/ml (>100 ug/L) at diagnosis and radiographic evidence of metastatic disease)
mjafri@ctg.queensu.ca613-533-6430
wparulekar@ctg.queensu.ca613-533-6430
Anchorage, Alaska 98508, United States
AKPAMC.OncologyResearchSupport@providence.org907-212-6871
Arroyo Grande, California 93420, United States
Burbank, California 91505, United States
Irvine, California 92612, United States
Newport Beach, California 92663, United States
Orange, California 92868, United States
San Luis Obispo, California 93401, United States
Torrance, California 90505, United States
West Haven, Connecticut 06516, United States
Wilmington, Delaware 19801, United States
Washington D.C., District of Columbia 20037, United States
Coral Gables, Florida 33146, United States
Coral Springs, Florida 33065, United States
Deerfield Beach, Florida 33442, United States
Gainesville, Florida 32610, United States
Hollywood, Florida 33021, United States
Miami, Florida 33136, United States
North Miami, Florida 33181, United States
Plantation, Florida 33324, United States
Clive, Iowa 50325, United States
Des Moines, Iowa 50309, United States
Des Moines, Iowa 50314, United States
Lexington, Kentucky 40509, United States
Louisville, Kentucky 40202, United States
Mount Sterling, Kentucky 40353, United States
Covington, Louisiana 70433, United States
Baltimore, Maryland 21287, United States
Ann Arbor, Michigan 48105, United States
Brighton, Michigan 48116, United States
Brownstown, Michigan 48183, United States
CTOResearch@hfhs.org313-916-3721
Clinton Township, Michigan 48038, United States
Lansing, Michigan 48910, United States
Crosslake, Minnesota 56442, United States
Detroit Lakes, Minnesota 56501, United States
International Falls, Minnesota 56649, United States
Pequot Lakes, Minnesota 56472, United States
Pine River, Minnesota 56474, United States
City of Saint Peters, Missouri 63376, United States
Lebanon, New Hampshire 03756, United States
Charlotte, North Carolina 28203, United States
Charlotte, North Carolina 28262, United States
Pinehurst, North Carolina 28374, United States
Fargo, North Dakota 58103, United States
Toledo, Ohio 43606, United States
Wooster, Ohio 44691, United States
Chadds Ford, Pennsylvania 19317, United States
Hazleton, Pennsylvania 18201, United States
Philadelphia, Pennsylvania 19104, United States
Wilkes-Barre, Pennsylvania 18711, United States
Houston, Texas 77030, United States
Seattle, Washington 98195, United States
Silverdale, Washington 98383, United States
Madison, Wisconsin 53718, United States
Madison, Wisconsin 53792, United States
Oconomowoc, Wisconsin 53066, United States
Stevens Point, Wisconsin 54482, United States
Saint John, New Brunswick E2L 4L2, Canada
Saint Catharines, Ontario L2S 0A9, Canada
905-682-6451
AKPAMC.OncologyResearchSupport@providence.org907-212-6871
AKPAMC.OncologyResearchSupport@providence.org907-212-6871
AKPAMC.OncologyResearchSupport@providence.org907-212-6871
AKPAMC.OncologyResearchSupport@providence.org907-212-6871
AKPAMC.OncologyResearchSupport@providence.org907-212-6871
Veronica.Stevenson@foundationhealth.org907-458-3043
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
clinical.trials@kp.org800-398-3996
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
clinical.trials@kp.org800-398-3996
clinical.trials@kp.org800-398-3996
towercancerresearch@toweroncology.com
Najee.Boucher@providence.org818-847-4793
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@commonspirit.org720-874-1881
becomingapatient@coh.org800-826-4673
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ccto-office@stanford.edu650-498-7061
clinical.trials@kp.org800-398-3996
clinical.trials@kp.org800-398-3996
ucstudy@uci.edu877-827-8839
877-467-3411
clinical.trials@kp.org800-398-3996
becomingapatient@coh.org800-826-4673
877-467-3411
clinical.trials@kp.org800-398-3996
uscnorrisinfo@med.usc.edu323-865-0451
323-865-0451
clinical.trials@kp.org800-398-3996
Cancer.trial.info@cshs.org310-423-2133
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
707-521-3830
323-865-0451
clinical.trials@kp.org800-398-3996
ucstudy@uci.edu877-827-8839
ccto-office@stanford.edu650-498-7061
800-455-0057
clinical.trials@kp.org800-398-3996
323-865-0451
clinical.trials@kp.org800-398-3996
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
clinical.trials@kp.org800-398-3996
ccto-office@stanford.edu650-498-7061
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
clinical.trials@kp.org800-398-3996
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
707-521-3830
707-521-3830
becomingapatient@coh.org800-826-4673
209-461-5257
818-981-3818
877-467-3411
courtney.steeneken@tmphysicians.com310-750-3300
becomingapatient@coh.org800-826-4673
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
clinical.trials@kp.org800-398-3996
720-848-0650
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
719-365-2406
719-364-6700
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ctsucontact@westat.com888-823-5923
970-470-7170
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
970-569-7429
970-297-6150
ctsucontact@westat.com888-823-5923
ctsucontact@westat.com888-823-5923
720-848-0650
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ctsucontact@westat.com888-823-5923
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
970-203-7083
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
203-937-3421 ext. 2832
research@beebehealthcare.org302-291-6730
research@beebehealthcare.org302-291-6730
lbarone@christianacare.org302-623-4450
lbarone@christianacare.org302-623-4450
lbarone@christianacare.org302-623-4450
research@beebehealthcare.org302-291-6730
lbarone@christianacare.org302-623-4450
jquiver1@jhmi.edu202-243-2373
202-741-2210
yenrique@msmc.com305-674-2625
305-243-2647
305-243-2647
305-243-2647
kginnity@med.miami.edu
trials@cancer.ufl.edu352-273-8675
305-243-2647
305-243-2647
305-243-2647
Yvonne.Enriquez@msmc.com305-674-2625
kginnity@med.miami.edu
305-243-2647
CancerAnswer@ccf.org954-659-5705
404-778-1868
888-946-7447
404-778-1868
404-851-7115
404-321-6111 ext. 7632
clinicaltrialsoncology@dekalbmedical.org440-778-1868
m.lisa.hwang@emory.edu404-778-5714
i.webster@hawaiicancercare.com808-524-6115
808-532-0315
808-545-8548
808-522-4333
808-586-2979
mmiyoshi@hawaiidrs.com808-792-7897
808-547-9816
808-531-8521
808-983-6090
808-433-6336
lori.kam@hawaiipacifichealth.org
808-535-7960
info@hawaiicancercare.com808-539-2273
808-486-6000
808-487-7447
808-522-4333
rohta@queens.org
eslinget@slhs.org208-381-2774
mccinfo@mtcancer.org406-969-6060
eslinget@slhs.org208-381-2774
eslinget@slhs.org208-381-2774
eslinget@slhs.org208-381-2774
mccinfo@mtcancer.org406-969-6060
mccinfo@mtcancer.org406-969-6060
eslinget@slhs.org208-381-2774
312-355-3046
Jrohde@emhc.org630-758-5460
630-646-6075
Cancerresearch@edward.org630-646-6075
dschwab@wustl.edu314-747-9912
844-793-0745
515-241-3305
sbenson@iora.org515-689-7658
319-365-4673
319-363-2690
515-241-3305
515-241-3305
515-241-3305
515-241-6727
515-241-3305
515-282-2200
515-241-3305
515-241-3305
trials@missioncancer.com515-282-2921
trials@missioncancer.com515-282-2921
515-241-3305
515-241-3305
515-875-9815
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
859-257-3379
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
502-562-3429
Cbcresearch@bhsi.com502-897-8592
ctoinfo@louisville.edu502-852-2755
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
clinicalresearch@marybird.com225-215-1353
504-584-6990
emede1@lsuhsc.edu504-210-3539
Elisemarie.curry@ochsner.org504-842-8084
jhcccro@jhmi.edu410-955-8804
frank.crum@christianacare.org410-443-1360
800-361-8387
CancerAnswerLine@med.umich.edu800-865-1125
ctoadmin@karmanos.org313-576-9790
800-865-1125
ctoadmin@karmanos.org313-576-9790
CTOResearch@hfhs.org313-916-3721
CTOResearch@hfhs.org313-916-3721
ctoadmin@karmanos.org800-527-6266
CTOResearch@hfhs.org313-916-3721
ctoadmin@karmanos.org313-576-9790
ctoadmin@karmanos.org313-576-9790
CTOResearch@hfhs.org313-916-3721
ctoadmin@karmanos.org313-576-9790
ctoadmin@karmanos.org313-576-9790
ctoadmin@karmanos.org313-576-9790
ctoadmin@karmanos.org313-576-9790
CTOResearch@hfhs.org313-916-3721
ctoadmin@karmanos.org313-576-9790
ctoadmin@karmanos.org313-576-9790
CTOResearch@hfhs.org313-916-3721
nhay@hfhs.org
CancerTrials@EssentiaHealth.org218-786-3308
218-828-2880
CancerTrials@EssentiaHealth.org218-786-3308
218-692-1010
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
218-365-7900
CancerTrials@EssentiaHealth.org218-786-3308
218-786-3308
218-283-9431
218-485-4481
CancerTrials@EssentiaHealth.org218-786-3308
218-568-4416
218-587-4416
coborncancercenter@centracare.com877-229-4907
CancerTrials@EssentiaHealth.org218-786-3308
218-894-7870
CancerTrials@EssentiaHealth.org218-786-3308
601-815-6700
info@siteman.wustl.edu800-600-3606
info@siteman.wustl.edu800-600-3606
info@siteman.wustl.edu800-600-3606
info@siteman.wustl.edu800-600-3606
info@siteman.wustl.edu800-600-3606
mccinfo@mtcancer.org406-969-6060
research@billingsclinic.org800-996-2663
mccinfo@mtcancer.org406-969-6060
mccinfo@mtcancer.org406-969-6060
mccinfo@mtcancer.org406-969-6060
ctsucontact@westat.com888-823-5923
mccinfo@mtcancer.org406-969-6060
mccinfo@mtcancer.org406-969-6060
amy.hanneman@providence.org406-327-3118
mccinfo@mtcancer.org406-969-6060
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
cancer.research.nurse@dartmouth.edu800-639-6918
eskwak@montefiore.org718-379-6866
800-804-9376
800-804-9376
800-804-9376
888-716-9259
800-804-9376
800-804-9376
800-804-9376
800-804-9376
980-442-0600
980-442-2000
jcwilliams@firsthealth.org910-715-3500
336-713-6771
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
CancerAnswer@ccf.org866-223-8100
800-641-2422
CTUReferral@UHhospitals.org800-641-2422
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
CTUReferral@UHhospitals.org800-641-2422
ababal@metrohealth.org216-778-7559
TaussigResearch@ccf.org866-223-8100
TaussigResearch@ccf.org866-223-8100
Jamesline@osumc.edu800-293-5066
TaussigResearch@ccf.org866-223-8100
CTUReferral@UHhospitals.org800-641-2422
PCIOncResearch@promedica.org419-824-1842
PCIOncResearch@promedica.org419-824-1842
TaussigResearch@ccf.org866-223-8100
TaussigResearch@ccf.org866-223-8100
877-231-4440
ou-clinical-trials@ouhsc.edu405-271-8777
nosall@stcharleshealthcare.org541-706-2909
CanRsrchStudies@providence.org503-215-2614
cherie.cox@bayareahospital.org541-269-8392
canrsrchstudies@provdience.org503-215-1979
research@asante.org541-789-4673
CanRsrchStudies@providence.org503-215-2614
CanRsrchStudies@providence.org503-215-2614
CanRsrchStudies@providence.org503-215-2614
CanRsrchStudies@providence.org503-215-2614
trials@ohsu.edu503-494-1080
541-706-2909
lbarone@christianacare.org302-623-4450
HemonCCTrials@geisinger.edu570-271-5251
hemoncctrials@geisinger.edu877-204-6081
HemonCCTrials@geisinger.edu570-459-2901
HemonCCTrials@geisinger.edu570-374-8555
ctsucontact@westat.com888-823-5923
HemonCCTrials@geisinger.edu800-275-6401
HemonCCTrials@geisinger.edu570-703-4768
HemonCCTrials@geisinger.edu570-271-5251
401-444-1488
hcc-clinical-trials@musc.edu843-792-9321
800-804-9376
800-811-8480
ctsucontact@westat.com888-823-5923
irb@houstonmethodist.org346-356-1413
ctsucontact@westat.com888-823-5923
burton@bcm.edu713-798-1354
713-873-2000
713-790-2700
800-553-2278
askmdanderson@mdanderson.org866-632-6789
ctsucontact@westat.com888-823-5923
832-522-2873
ctsucontact@westat.com888-823-5923
281-242-2873
hmthewoodlands@houstonmethodist.org713-790-2700
cancerinfo@hci.utah.edu888-424-2100
cancer.research.nurse@hitchcock.org800-639-6918
uvacancertrials@hscmail.mcc.virginia.edu434-243-6303
anne_carmellat@bshsi.org804-893-8978
anne_carmellat@bshsi.org804-893-8978
anne_carmellat@bshsi.org804-893-8978
anne_carmellat@bshsi.org804-893-8978
Anne_caramella@bshsi.org804-893-8978
deidre.dillon@providence.org360-412-8958
425-454-2148
achapman1@peacehealth.org360-788-8223
deidre.dillon@providence.org360-412-8958
PCRC-NCORP@Swedish.org206-215-2343
marilyn.birchman@providence.org425-261-3529
PCRC-NCORP@Swedish.org206-215-2343
research@kadlecmed.org509-783-4637
425-899-6000
deidre.dillon@providence.org360-412-8958
kmakin-bond@peacehealth.org360-514-2016
rcccclinicalresearch@skagitvalleyhospital.org360-814-2182
PCRC-NCORP@Swedish.org206-215-3086
800-804-8824
PCRC-NCORP@Swedish.org206-215-3086
PCRC-NCORP@Swedish.org206-215-2343
206-606-5800
800-804-8824
achapman1@peacehealth.org360-788-8239
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
research@ccnw.net509-228-1680
research@ccnw.net509-228-1680
research@ccnw.net509-228-1680
kmakin-bond@peacehealth.org360-514-3940
Cheryl.Dodd@providence.org509-897-5993
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
oncology.clinical.trials@marshfieldresearch.org800-782-8581
CancerTrials@EssentiaHealth.org218-786-3308
218-568-4416
clinicaltrials@cancer.wisc.edu800-622-8922
clinicaltrials@cancer.wisc.edu800-622-8922
oncology.clinical.trials@marshfieldresearch.org800-782-8581
oncology.clinical.trials@marshfieldresearch.org800-782-8581
CancerTrials@EssentiaHealth.org218-786-3308
oncology.clinical.trials@marshfieldresearch.org800-782-8581
701-364-6272
oncology.clinical.trials@marshfieldresearch.org800-782-8581
ctsucontact@westat.com888-823-5923
research@billingsclinic.org800-996-2663
780-432-8500
888-939-3333
ctu_web@cancercare.mb.ca866-561-1026
506-648-6890
japaquette@hrsrh.on.ca706-522-6237 ext. 2401
905-387-9495
cc-clinicaltrials@kgh.kari.net613-549-6666
research@wrhn.ca519-749-4370
519-685-8600
905-813-4040
613-761-4395
416-480-5000
clinical.trials@uhn.on.ca416-946-4501
450-466-5065
514-252-3400 ext. 3329
514-340-8222 ext. 8248
ctsucontact@westat.com888-823-5923
306-655-2914
(52) 5628-0400
comunicaciones@msp.gub.uy598 2 4000101 X 1934